|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation expense, intangible asset and other amortization | |||||
| Stock-based compensation | |||||
| Amortization of deferred commissions | |||||
| Payments of deferred commissions | |||||
| Equity in (earnings) loss of equity method investments | |||||
| Realized and unrealized (gains) losses on investments, net | |||||
| Consolidated Entity excluding Consolidated Investment Products | |||||
| Consolidated Investment Products | |||||
| Purchases of investments by CIP | |||||
| Sales of investments by CIP | |||||
| Net proceeds (purchases) of short-term investments and securities sold short by CIP | |||||
| Change in other assets and liabilities of CIP | |||||
| Amortization of discount on notes payable of CIP | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital expenditures and other asset purchases | |||||
| Purchase of equity method investment | |||||
| Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net | |||||
| Acquisition of business, net of cash acquired of $4,395 for the year ended December 31, 2023 | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Refinancing and borrowings on credit agreement | |||||
| Repayments on credit agreement | |||||
| Payment of deferred financing costs | |||||
| Payment of contingent consideration | |||||
| Repurchase of common shares | |||||
| Common stock dividends paid | |||||
| Taxes paid related to net share settlement of restricted stock units | |||||
| Investment management subsidiary equity sales (purchases) | |||||
| Net contributions from (distributions to) noncontrolling interests | |||||
| Borrowings by CIP | |||||
| Payments on borrowings by CIP | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities | |||||
| Common stock dividends payable | |||||
| Contingent consideration | |||||
| Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net | |||||
| Reconciliation of cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Consolidated Entity excluding Consolidated Investment Products | |||||
| Consolidated Investment Products | |||||
| Cash pledged or on deposit of consolidated investment products | |||||
| Distributions from equity method investments | |||||
| Change in fair value of contingent consideration | |||||
| Deferred taxes, net | |||||
| Lease termination | |||||
| Changes in operating assets and liabilities: | |||||
| Sales (purchases) of investments, net | |||||
| Accounts receivable, net and other assets | |||||
| Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities | |||||
Loading...